Rearrangement of p53 gene with overexpressed p53 protein in primary cervical cancer

被引:0
作者
Sahu, GR [1 ]
Nayak, BK [1 ]
Patnaik, S [1 ]
Parija, T [1 ]
Das, BR [1 ]
机构
[1] Inst Life Sci, Mol Oncol & Med Biotechnol Div, Bhubaneswar 751023, Orissa, India
关键词
p53; mutation; rearrangement; overexpression; cervical cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The frequency of p53 mutations is low and there is evidence of p53 protein overexpression even without p53 mutations in cervical cancers. This suggests that alternative mechanisms other than p53 mutation could be responsible for tumourigenesis of the uterine cervix. Therefore, an attempt has been made in the present investigation to analyze mutation and rearrangement of p53 gene in primary cervical cancers. The results indicated absence of mutation and presence of rearrangement in about 35% of cervical cancer patients. However, p53 overexpression in 50% of patients was demonstrated by immunohistochemistry and Western blot analysis. Further, rearrangement of p53 has been correlated with p53 mRNA and p53 protein status. The results indicated presence of overexpressed p53 protein in the samples with rearranged p53 gene. Thus, it is presumed that rearrangement of p53 might lead to production of defective p53 protein by affecting the level of p53 protein and this might have a role in the process of tumourigenesis. This study reports for the first time rearrangement of p53 in cervical cancers.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 45 条
[1]   A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides [J].
Agarwal, ML ;
Agarwal, A ;
Taylor, WR ;
Chernova, O ;
Sharma, Y ;
Stark, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14775-14780
[2]   ALTERATIONS IN THE P53 GENE AND THE CLONAL EVOLUTION OF THE BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ADVANI, SH ;
BENCHIMOL, S ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6783-6787
[3]  
AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
[4]   Expression and mutational analysis of P53 in stage IB and IIA cervical cancers [J].
Benjamin, I ;
Saigo, P ;
Finstad, C ;
Takahashi, H ;
Federici, M ;
Rubin, SC ;
Boyd, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (05) :1266-1271
[5]   GENERAL METHOD FOR ISOLATION OF HIGH MOLECULAR-WEIGHT DNA FROM EUKARYOTES [J].
BLIN, N ;
STAFFORD, DW .
NUCLEIC ACIDS RESEARCH, 1976, 3 (09) :2303-2308
[6]   p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor [J].
Budhram-Mahadeo, V ;
Morris, PJ ;
Smith, MD ;
Midgley, CA ;
Boxer, LM ;
Latchman, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :15237-15244
[7]  
Castrén K, 1998, INT J CANCER, V77, P674, DOI 10.1002/(SICI)1097-0215(19980831)77:5<674::AID-IJC2>3.0.CO
[8]  
2-S
[9]   CLONAL P53 MUTATION IN PRIMARY CERVICAL-CANCER - ASSOCIATION WITH HUMAN-PAPILLOMAVIRUS-NEGATIVE TUMORS [J].
CROOK, T ;
WREDE, D ;
TIDY, JA ;
MASON, WP ;
EVANS, DJ ;
VOUSDEN, KH .
LANCET, 1992, 339 (8801) :1070-1073
[10]   PROPERTIES OF P53 MUTATIONS DETECTED IN PRIMARY AND SECONDARY CERVICAL CANCERS SUGGEST MECHANISMS OF METASTASIS AND INVOLVEMENT OF ENVIRONMENTAL CARCINOGENS [J].
CROOK, T ;
VOUSDEN, KH .
EMBO JOURNAL, 1992, 11 (11) :3935-3940